The world is awash in a ‘chamorro’ plant that’s been shown to cure cancer and improve immune function

The world has been awash with a growing number of medicinal plants that have been shown in some form to help people in various ways, but there is a growing body of evidence to show they may also be helpful for other ailments.

Now, new research suggests one of the plant’s most promising uses may be in treating people with a rare and often deadly form of lung cancer.

Chamorros are tiny plant that are also used as food supplements.

They are often used to treat the effects of the common cold, but researchers in Brazil found that they can be used to fight lung cancer too.

In a study published this week in the journal PLOS One, researchers at the Universidade Federal do Campinas (UFCP) used the herb to help fight lung tumors.

The plant is named after the ancient Greek city of Campanhas, which in turn is named for a legendary Greek philosopher and scientist, Archimedes.

The research was led by Carlos Marinho dos Santos, a professor of plant and animal science at the UFCP and a member of the Institute of Experimental Biology and Biotechnology (IIB).

“I think it’s amazing, because in the world of medicine it’s really hard to find a good remedy for something that you have a disease that you can’t treat,” said dos Santos.

The study was conducted in Brazil, where it is believed there are around 2.3 million lung cancer cases in the country each year.

It is estimated that the disease kills around 20,000 people in the entire country every year.

In order to find out more about the medicinal properties of the herb, dos Santos and his colleagues wanted to know if it could be used in people with the lung cancer-causing variant of the disease called PRN-2.

The variant causes a mutation that causes the cancer to grow and then spread, with the cancer eventually reaching a large part of the body.

The disease is known as PRN2, or PRN+2.

Researchers have found that a number of different strains of the lung disease can be controlled with various forms of the chemical chloroquine, which is commonly used to cure PRN1, and the compound chloroquinol, which also works to stop the spread of the tumor.

But none of those treatments have been found to have any clinical efficacy for treating PRN.

To find out whether the herb could help fight the lung tumor, dos and his team tested the herb against a number other tumors that were not on the list.

The results showed that it had some potential.

The team tested four different versions of the compound, which were then put into two different types of lung tumors: two PRN 2 and two PRNS1, to see how effective they were at killing the tumors.

The results showed the compound worked against both of the PRN mutations, and it was most effective at killing PRNS2, which was the most common form of the mutation.

The study showed that the compound was able to kill the tumors in one test tube and not the other.

The researchers then looked at the lung tumors that had been treated with a mixture of the two compounds.

In this particular study, the researchers found that the combination of the compounds was able not only to kill all of the tumors but also stop the disease in a large number of lung tissue samples from the tumors, which could indicate that it might be able to do something similar to what is used for other treatments for PRN in people.

In the study, dos was able, with a little bit of luck, to find some of the same patients who had been tested in previous studies, but also some of those who had not.

The combination of compounds that he found did not affect the tumors’ growth at all, but the study did show that it slowed the spread in some cases of the cancer.

“It does seem to work, but it’s still very early days.

It’s not going to be able, as you can see, to prevent the disease from spreading,” said Dos Santos.

“It will probably work if you take some of these patients and you use this combination for several years.

It would probably work in the same way for a patient that has been treated for PRNS, for example, who also has PRN, or maybe for a person who has PRNS and PRN++.””

But at the moment, it’s too early to tell whether or not this combination is going to work,” he said.

The findings are not entirely unexpected, as it is a common misconception that the compounds work by slowing the spread and killing the tumor, as they did not kill the tumor itself.

But dos Santos thinks the combination is likely to have some benefits as well.

The most important thing to take away from this is that this is a new treatment for lung cancer that we have not seen before,